Fluid-attenuated inversion recovery (FLAIR), cerebral blood flow (CBF), cerebral oxygen metabolism (CMRO2), oxygen extraction fraction (OEF), ischemic brain volume (IBV), fluorine 18–labeled fluoromisonidazole ([18F]FMISO) trapping rate (k3), and hypoxic brain volume (HBV) are shown in patient 10, who sustained a head injury after a fall. During imaging, cerebral perfusion pressure was 82 mm Hg, and intracranial pressure was 12 mm Hg. The FLAIR image demonstrates bilateral contusions within the temporal and parietal lobes on the right and the temporal lobe on the left. Cerebral blood flow is low in these regions, particularly on the right side. Cerebral oxygen metabolism is mildly reduced within the right temporal region, but a large increase in the OEF is seen, particularly within the right but also within the left temporal and parietal cortices. Increased k3 values are found within the right temporal region but also across other injured and normal-appearing regions. The region with a critical increase in OEF above the individually calculated ischemic threshold (IBV) and the HBV are both shown in red overlying the FLAIR image. Within the total IBV of 131 mL in this patient, the mean CBF was 14 mL/100 mL/min; CBV, 3.4 mL/100 mL; CMRO2, 84 μmol/100 mL/min; and OEF, 90%. The total HBV in this patient was 70 mL, with a mean CBF of 13 mL/100 mL/min; CBV, 2.2 mL/100 mL; CMRO2, 47 μmol/100 mL/min; and OEF, 49%. The volume of overlap between these 2 tissues classes in this patient was 6 mL.
Box and whisker plots of cerebral blood flow, cerebral blood volume, cerebral oxygen metabolism, and oxygen extraction fraction in brain tissue constituting the HBV, IBV, brain tissue that appeared to be structurally normal (normal appearance), and healthy volunteers (control). The central lines in each box denote median values; lower and upper boundaries, the 25th and 75th percentiles, respectively; error bars, the 10th and 90th percentiles, and solid circles, outliers. For all comparisons, Mann-Whitney tests with Bonferroni correction were used.
aP < .01, IBV vs normal appearance.
bP < .01, HBV vs control.
cP < .01, IBV vs control.
dP < .05, HBV vs normal appearance.
Fluid-attenuated inversion recovery (FLAIR), cerebral blood flow (CBF), oxygen extraction fraction (OEF), ischemic brain volume (IBV), 18F-FMISO trapping rate (k3), and hypoxic brain volume (HBV) are shown in patient 9, who sustained a head injury after a fall. During imaging, cerebral perfusion pressure was 80 mm Hg and intracranial pressure was 21 mm Hg. The FLAIR image demonstrates hemorrhagic contusions with surrounding vasogenic edema within bilateral frontal and right temporal regions. Additional areas of high signal consistent with injury are evident within the left thalamus and bilateral occipital regions. Thin subdural hematomas are seen over the right cortex and left frontal region. Cerebral blood flow is low within the frontal regions and is associated with increased k3 values in the absence of an increase in OEF consistent with conventional macrovascular ischemia. The HBV (100 mL) in this patient had a mean CBF of 14 mL/100 mL/min; cerebral blood volume (CBV), 2.1 mL/100 mL; cerebral oxygen metabolism, 27 μmol/100 mL/min; and OEF, 35%. These values did not match the region of brain within the IBV (149 mL), with a mean CBF of 15 mL/100 mL/min; CBV, 3.4 mL/100 mL; CMRO2, 63 μmol/100 mL/min; and OEF, 88%. The volume of overlap between these 2 tissues classes in this patient was 10 mL.
The association between the oxygen extraction fraction (OEF) and fluorine 18–labeled fluoromisonidazole ([18F]FMISO) trapping rate (k3) within voxels across the whole brain of individual patients (n = 10) is plotted using locally weighted scatterplot smoothing (LOWESS) with 66% tension45 in Statview software (version 5; SAS Institute Inc). LOWESS is an outlier-resistant method based on local polynomial fits.46 For this comparison, voxels with cerebral oxygen metabolism of less than 37.6 μmol/100 mL/min were excluded based on the lower 95% CI for nonlesion voxels after head injury.5
eFigure. Regional Physiology
Customize your JAMA Network experience by selecting one or more topics from the list below.
Veenith TV, Carter EL, Geeraerts T, et al. Pathophysiologic Mechanisms of Cerebral Ischemia and Diffusion Hypoxia in Traumatic Brain Injury. JAMA Neurol. 2016;73(5):542–550. doi:10.1001/jamaneurol.2016.0091
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Combined oxygen 15–labeled positron emission tomography (15O PET) and brain tissue oximetry have demonstrated increased oxygen diffusion gradients in hypoxic regions after traumatic brain injury (TBI). These data are consistent with microvascular ischemia and are supported by pathologic studies showing widespread microvascular collapse, perivascular edema, and microthrombosis associated with selective neuronal loss. Fluorine 18–labeled fluoromisonidazole ([18F]FMISO), a PET tracer that undergoes irreversible selective bioreduction within hypoxic cells, could confirm these findings.
To combine [18F]FMISO and 15O PET to demonstrate the relative burden, distribution, and physiologic signatures of conventional macrovascular and microvascular ischemia in early TBI.
Design, Setting, and Participants
This case-control study included 10 patients who underwent [18F]FMISO and 15O PET within 1 to 8 days of severe or moderate TBI. Two cohorts of 10 healthy volunteers underwent [18F]FMISO or 15O PET. The study was performed at the Wolfson Brain Imaging Centre of Addenbrooke’s Hospital. Cerebral blood flow, cerebral blood volume, cerebral oxygen metabolism (CMRO2), oxygen extraction fraction, and brain tissue oximetry were measured in patients during [18F]FMISO and 15O PET imaging. Similar data were obtained from control cohorts. Data were collected from November 23, 2007, to May 22, 2012, and analyzed from December 3, 2012, to January 6, 2016.
Main Outcomes and Measures
Estimated ischemic brain volume (IBV) and hypoxic brain volume (HBV) and a comparison of their spatial distribution and physiologic signatures.
The 10 patients with TBI (9 men and 1 woman) had a median age of 59 (range, 30-68) years; the 2 control cohorts (8 men and 2 women each) had median ages of 53 (range, 41-76) and 45 (range, 29-59) years. Compared with controls, patients with TBI had a higher median IBV (56 [range, 9-281] vs 1 [range, 0-11] mL; P < .001) and a higher median HBV (29 [range, 0-106] vs 9 [range, 1-24] mL; P = .02). Although both pathophysiologic tissue classes were present within injured and normal appearing brains, their spatial distributions were poorly matched. When compared with tissue within the IBV compartment, the HBV compartment showed similar median cerebral blood flow (17 [range, 11-40] vs 14 [range, 6-22] mL/100 mL/min), cerebral blood volume (2.4 [range, 1.6- 4.2] vs 3.9 [range, 3.4-4.8] mL/100 mL), and CMRO2 (44 [range, 27-67] vs 71 [range, 34-88] μmol/100 mL/min) but a lower oxygen extraction fraction (38% [range, 29%-50%] vs 89% [range, 75%-100%]; P < .001), and more frequently showed CMRO2 values consistent with irreversible injury. Comparison with brain tissue oximetry monitoring suggested that the threshold for increased [18F]FMISO trapping is probably 15 mm Hg or lower.
Conclusions and Relevance
Tissue hypoxia after TBI is not confined to regions with structural abnormality and can occur in the absence of conventional macrovascular ischemia. This physiologic signature is consistent with microvascular ischemia and is a target for novel neuroprotective strategies.
Previous studies1,2 have used oxygen 15–labeled positron emission tomography (15O PET) to define evidence of cerebral ischemia after early traumatic brain injury (TBI). Although other 15O PET studies3,4 have found less convincing evidence of ischemia, they typically demonstrate evidence of metabolic dysfunction that correlates with focal microdialysis. The relevance of such early physiologic derangements are evidenced by their association with local tissue fate,5,6 chronic brain atrophy,4 and clinical outcome.1
Although nonischemic derangements after TBI7 have been attributed to mitochondrial dysfunction,3,8,9 studies have shown reductions in brain tissue Po2 (Pbto2).10-12 These Pbto2 reductions are associated with worse outcome,10-12 and interventions aimed at optimizing oxygen delivery show promise.10,13,14 These discordant findings are best explained by an increased gradient for oxygen diffusion from the cerebral microvasculature to the interstitium. A previous study15 used Pbto2 monitoring and 15O PET to demonstrate increased gradients for oxygen diffusion within hypoxic regions in the absence of macrovascular ischemia. Further, several investigators15-17 have shown that diffusion barrier ischemia can be explained by microvascular failure due to endothelial swelling, perivascular edema, and microthrombosis, particularly surrounding focal lesions.
Fluorine 18–labeled fluoromisonidazole ([18F]FMISO) is a hypoxia PET tracer that undergoes irreversible selective bioreduction within hypoxic but viable cells18 and has been used after stroke19-21 and subarachnoid hemorrhage.22 This study is the first clinical investigation, to our knowledge, to combine [18F]FMISO with 15O PET measurement of cerebral blood flow (CBF), cerebral blood volume (CBV), cerebral oxygen metabolism (CMRO2), and oxygen extraction fraction (OEF) to interrogate pathophysiologic derangements. Imaging tissue hypoxia in the absence of macrovascular ischemia would confirm evidence of microvascular ischemia. We aimed to use [18F]FMISO and 15O PET to demonstrate the burden, distribution, and physiologic signatures of conventional macrovascular and microvascular ischemia after TBI.
Question Do cerebral ischemia and diffusion hypoxia have distinct pathophysiologic mechanisms in traumatic brain injury (TBI)?
Findings In this case-control study using oxygen 15–labeled and fluorine 18–labeled fluoromisonidazole positron emission tomography in 10 patients with TBI and 20 controls, tissue hypoxia after TBI was not confined to regions with structural abnormality and could occur in the absence of conventional ischemia.
Meaning This physiologic signature is consistent with microvascular ischemia and is a target for novel neuroprotective strategies.
Ten patients with TBI (9 men and 1 woman) with a median age of 59 (range, 30-68) years were recruited from Addenbrooke’s Hospital. The patients presented with a median postresuscitation Glasgow Coma Scale score of 7 (range, 3-12), but required sedation and ventilation for control of intracranial pressure (Table). Patient management included protocol-driven care aiming for an intracranial pressure of less than 20 mm Hg, cerebral perfusion pressure of greater than 65 mm Hg, and, where available, Pbto2 values of greater than 15 mm Hg.14,24 Patients who received surgical intervention or second-tier medical therapies (barbiturate coma or moderate hypothermia [33°C-35°C]) are specified in the Table. The outcome was evaluated using the Glasgow Coma Scale at 6 months. Ten healthy volunteers (8 men and 2 women) with a median age of 45 (range, 29-59) years underwent 15O PET and another 10 healthy volunteers (8 men and 2 women) with a median age of 53 (range, 41-76) years underwent [18F]FMISO PET (control groups). The Cambridge Central Research Ethics Committee and Administration of Radioactive Substances Advisory Committee approved this study. Written informed consent or consultee agreement from the next-of-kin was obtained in accordance with the Declaration of Helsinki.25
Data were collected from November 23, 2007, to May 22, 2012. Participants underwent magnetic resonance imaging using a 3-T scanner (Magnetom Verio; Siemens AG) within the Wolfson Brain Imaging Centre at the University of Cambridge. Sequences included a 3-dimensional T1-weighted magnetization prepared rapid gradient echo (MPRAGE), fluid-attenuated inversion recovery (FLAIR), gradient echo, and susceptibility-weighted imaging. Patients underwent 15O PET, followed by [18F]FMISO PET in the same session and scanner (Advance; GE Medical Systems), with FMISO injection at least 15 minutes after 15O delivery.
Emission data were acquired in 3-dimensional mode for the last 10 minutes of a 20-minute steady-state infusion of 800 MBq of 15O water, in 3-dimensional mode for 5 minutes after a 1-minute inhalation of 750 MBq of 15O carbon monoxide, and in 2-dimensional mode for the last 10 minutes of a 20-minute steady-state inhalation of 7200 MBq of 15O oxygen (to convert to megacuries, multiply by 2.7 × 10−11). Parametric maps of CBF, CBV, CMRO2, and OEF were calculated by inputting simultaneous PET and arterial tracer radioactivity concentration measurements into standard models.1
After [18F]FMISO injection (300 MBq), PET data were acquired in 3-dimensional mode for 2.5 hours. Arterial plasma samples provided the input function for kinetic analysis. Voxel-wise compartmental modeling used the irreversible version of BAFPIC, a basis function approach to 2-tissue compartmental modeling with a plasma input function.26 Hypoxia was mapped using the parameter k3 determined from BAFPIC, which denotes the tissue-trapping rate of [18F]FMISO.27
We processed the PET data using an integrated image analysis gateway (PETAn)28 that incorporates Statistical Parametric Mapping (SPM; Wellcome Department of Imaging Neuroscience, University College London), Matlab (MathWorks, Inc), and Analyze (AnalyzeDirect, Inc). Using the brain extraction tool in the FMRIB Software Library,29 the skull and extracranial soft tissue were stripped from the MPRAGE and the extracted brain registered to the summed H215O and [18F]FMISO images. The cerebrospinal fluid segment and CBF voxels of less than 2.36 mL/100 mL/min consistent with the core lesion in PET studies were removed based on a positive predictive value of 0.95 for nonviable tissue.5 To avoid artifacts within regions of obvious injury, analyses were conducted in native PET space, rather than using spatial transformation to a standard template.20,30
Focal contusions were defined on FLAIR and segregated into core, contusion, and pericontusion using MPRAGE, gradient echo, and susceptibility-weighted imaging.30 The lesion core was identified as a region of mixed-signal intensity consistent with hemorrhage and necrotic tissue and excluded from subsequent analyses. Contusion was identified as an area of high FLAIR signal consistent with edema; pericontusion, as a 1-cm border zone of normal-appearing tissue surrounding a contusion. The FLAIR images were coregistered to PET space using SPM8, and coregistration parameters were applied to lesion regions of interest. For comparison, a region of normal-appearing mixed gray and white matter was defined in the patients with TBI.
We used OEF to assess the burden of ischemia with a technique that was previously validated in TBI.1,2,31 We estimated an individualized critical OEF threshold (OEFcrit) (which equated to a cerebral venous oxygen content [CvO2] of 3.5 mL/100 mL) for each participant using OEFcrit = (CaO2 − 3.5)/CaO2, where CaO2 = 1.34 HbSao2 + 0.0225Pao2. CaO2 is arterial oxygen content, Hb is the hemoglobin concentration in grams per 100 mL, Sao2 is the fractional arterial oxygen saturation, and Pao2 is the arterial Po2. Application of these patient-specific OEF thresholds allowed calculation of the volume of voxels with CvO2 values below this threshold, and hence estimation of the ischemic brain volume (IBV).
We used k3 values to assess the burden of tissue hypoxia because k3 represents the rate constant for FMISO trapping under hypoxic conditions. Using the mean and SD of voxel k3 values within the whole brain of each control participant, we calculated the upper 99% CI threshold using the mean plus 3 SDs. We used the brain volume with k3 values above this threshold to calculate the hypoxic brain volume (HBV). We examined the volume, spatial location, and mismatch between the HBV and IBV.
For participants who underwent Pbto2 monitoring, monitoring was continuous with values recorded every 5 to 10 minutes throughout PET. A 20-mm-diameter region of interest15 was drawn around the sensor tip (LICOX; Integra Neurosciences Corp), and the [18F]FMISO k3 values were compared with Pbto2 values.
Data were analyzed from December 3, 2012, to January 6, 2016. Statistical analyses were conducted using Statview (version 5; SAS Institute Inc). Data are expressed as median (range), unless otherwise stated. Data were compared using Mann-Whitney and Spearman rank correlation tests and P values quoted after Bonferroni correction (where appropriate), with corrected P < .05 considered significant. The Dice similarity coefficient32 was used to measure the degree of spatial overlap between IBV and HBV.
Physiologic findings were highly variable even within regions that appeared structurally normal (eFigure in the Supplement). When compared with data from controls, contusions showed lower CBF and CMRO2 (P < .01, Mann-Whitney test with Bonferroni correction), whereas CBV and OEF were variable but similar to those of the controls. Pericontusional tissue and regions that appeared structurally normal had lower CMRO2 than tissue in controls (P < .01, Mann-Whitney test with Bonferroni correction), whereas CBF, CBV, and OEF were similar to those of controls.
When compared with controls, the IBV in the patient group was significantly higher (56 [9-281] mL vs 1 [0-11] mL; P < .001, Mann-Whitney test). Although much of the IBV was close to visible lesions, with 23% (4%-65%) found within contusional and pericontusional regions, the IBV was also distributed across normal-appearing brain tissue (Figure 1). Physiologic features within the IBV are shown in Figure 2. We found no association between the IBV and days since injury or age (P = .49 and P = .34, respectively, Spearman correlation rank test).
The HBV was variable but significantly higher in patients compared with controls, with a median of 29 (0-106) mL vs 9 (1-24) mL (P = .02, Mann-Whitney test). A group change toward correlation between the IBV and HBV failed to achieve significance (ρ = 0.61 and P = .07, Spearman rank correlation test). The overlap volume between these 2 pathophysiologic tissue classes was 1 (0-19) mL, and we found substantial spatial mismatch (Dice similarity coefficient, 0 [0-0.1]) (Figure 1 and Figure 3). Although the HBV was often related to visible lesions, with 37% (21%-57%) found within contusional and pericontusional regions, HBV was also seen within normal-appearing brain tissue (Figures 1 and 3). Figure 2 compares summary physiologic data from the IBV and HBV tissue classes, tissue that appeared structurally normal and was in neither of these classes, and tissue from controls. When tissue constituting the HBV was compared with tissue within the IBV (Figure 2), they showed similar median CBF (17 [range, 11-40] vs 14 [range, 6-22] mL; P = .22), CBV (2.4 [range, 1.6-4.2) vs 3.9 [range, 3.4-4.8] mL/100 mL; P = .09), and CMRO2 (44 [range, 27-67] vs 71 [range, 34-88] μmol/100 mL/min; P = .14), but lower OEF (38% [range, 29%-50%] vs 89% [range, 75%-100%]; P < .001, Mann-Whitney tests with Bonferroni correction). Cerebral metabolism below published 15O PET thresholds for irreversible injury (37.6 μmoL/100 mL/min) in TBI5 was observed in 3 of 10 patients in the HBV tissue class compared with 1 within the IBV tissue class. We found no relationship between the HBV and the days since injury or age (P = .70 and P = .90, respectively, Spearman rank correlation test).
Brain tissue Po2 was available in 5 participants, and measurements during PET were 34 (16-55) mm Hg. The region of interest around the probe tip showed no [18F]FMISO k3 or OEF values that exceeded our HBV and IBV thresholds.
By combining 15O and [18F]FMISO PET, we demonstrate evidence of conventional macrovascular cerebral ischemia and tissue hypoxia as long as 1 week after TBI. Spatial matching of these 2 tissue classes was poor, with voxels contributing to the HBV more frequently found within the vicinity of lesions. The IBV and HBV voxels showed comparable reductions in CBF, but the HBV tissue class showed a tendency toward lower CBV and CMRO2 and significantly lower OEF. Further, the HBV more frequently exhibited CMRO2 values within the range of irreversible injury. Although the IBV identifies conventional macrovascular ischemia, the coexistence of normal OEF (identified by 15O PET) and low tissue Po2 (identified by high [18F]FMISO trapping) in the HBV is the typical signature of diffusion barrier hypoxia that, along with lower CBV, implies microvascular collapse and ischemia as an underlying mechanism. These findings confirm the existence of diffusion hypoxia, characterize its pathophysiologic signature as distinct from macrovascular ischemia, and show that they have incomplete spatial concordance. Diffusion hypoxia is a potential target for future novel neuroprotective strategies.
Although 15O and [18F]FMISO PET have been used separately to identify ischemia,19-21,33 we combined both tracers to interrogate pathophysiologic derangements after TBI. For [18F]FMISO PET, we used kinetic analysis to calculate k3 as a measure of hypoxia. Although the influx rate constant (Ki)34 is often used to quantify irreversible trapping or metabolism of a tracer in tissue, it is sensitive to changes in tracer delivery, which is CBF dependent. This confounding issue is obviated through estimation of k3, the rate constant for tissue [18F]FMISO trapping, and in the context of low CBF in the vicinity of contusions,35,36 k3 is more suited to represent trapping of [18F]FMISO within hypoxic brain tissue.27,37 The HBV was calculated from the total volume of voxels with k3 values larger than the upper 99% CI value from control data.
Because derangements are common across the whole brain after TBI,1,6,35 we cannot use a similar approach to that used after ischemic stroke that defined increased [18F]FMISO trapping greater than the upper 99% CI value from contralateral brain.38 Other studies20,21 used spatial normalization and voxel-wise statistical testing to compare with controls. These approaches are less applicable to TBI because structural distortions are usually larger, making spatial normalization less dependable. We sought to identify [18F]FMISO trapping within areas of obvious injury and normal-appearing regions, and therefore, used native PET space analyses to avoid artifacts from such processing techniques.30,39 The volumes of hypoxic brain with increased [18F]FMISO trapping in our participants were similar to those seen in ischemic stroke,19,40 with a mean HBV of 47 mL in our patients and 4 patients with an HBV of at least 5% of brain volume.
We removed lesion core using magnetic resonance imaging and excluding voxels where CBF was less than 2.36 mL/100 mL/min based on a positive predictive value of 0.95 for nonviable tissue in TBI.5 After TBI, increased FLAIR signal can disappear on sequential imaging41 and is not predictive of pan necrosis for all lesion voxels.5 Because derangements are often found in normal-appearing regions,6 we examined the whole brain, but highlighted when these regions were found within the vicinity of lesions using standard magnetic resonance imaging sequences. The mean HBV found outside contusion and pericontusion areas was 30 (0-75) mL, and 4 participants had greater than 50 mL of such tissue.
These results have implications for our understanding of oxygen delivery and use in clinical TBI. Although the HBV and IBV showed some overlap, most IBV voxels did not show significant [18F]FMISO trapping. This finding suggests that at least some of the voxels with OEF in excess of our threshold CvO2 values could maintain tissue Po2 levels above those that result in irreversible bioreduction of [18F]FMISO. The Po2 at which bioreduction occurs is unclear, but in vitro data show that, although FMISO bioreduction shows some enhancement with Po2 of less than 60 mm Hg, it rises steeply at a Po2 of less than 10 mm Hg.42 Given that the normal Pbto2 is approximately 25 mm Hg,43,44 many IBV voxels may have had Pbto2 values in the range of 10 to 20 mm Hg, and our HBV threshold may simply be a more stringent physiologic marker of tissue hypoxia. In comparison with the IBV, CMRO2 below thresholds previously identified for survival5 was more common in the HBV. Although [18F]FMISO trapping does not occur within necrotic tissue,18 a proportion of these voxels may be destined for infarction, and the HBV may provide a more specific marker of tissue on the cusp of survival.
To explore the relationship between OEF and [18F]FMISO k3 within viable brain, we excluded voxels at high risk for infarction based on the lower 95% CI for nonlesion brain after TBI, using a CMRO2 threshold of 37.6 μmol/100 mL/min.5 In Figure 4, the subsequent relationship between OEF and k3 values within individual patients is shown using locally weighted scatterplot smoothing.6,45,46 This association shows variability between patients, with a subset showing increased [18F]FMISO trapping above an OEF threshold of approximately 60% to 70%, broadly consistent with conventional ischemia. We must emphasize that levels of [18F]FMISO trapping were, in most cases, below our HBV thresholds and equivalent to tissue Po2 levels of about 10 to 25 mm Hg.42
Given that these data provide a transition zone between normal tissue and tissue that shows increased [18F]FMISO trapping, physiologic characterization of tissue that shows pathologic levels of [18F]FMISO trapping would be useful. Although participants showed increased [18F]FMISO trapping across the whole brain, none was found within the vicinity of focal Pbto2 monitoring probes. Clinically significant reductions in Pbto2 are typically reported below 10 to 15 mm Hg,47 and our local treatment protocol aims to maintain values of greater than 15 mm Hg, which were achieved in all participants. The lowest Pbto2 level recorded during PET was 16 mm Hg. In terms of the threshold value at which [18F]FMISO trapping occurs in TBI, we can conclude that Po2 values within the HBV may have been no greater than 10 to 15 mm Hg.
The proportion of HBV voxels that had high OEF meeting the criteria for macrovascular ischemia (IBV) was small (8%). This finding may relate to the fact that our patients underwent imaging 1 to 8 days after injury, at a time when conventional ischemia is less prevalent,1,48 but lesions remain at risk for expansion.30,39 This timing may have meant that many tissue regions showed complex and varying mixtures of macrovascular ischemia and diffusion hypoxia, making detection of clear OEF thresholds for [18F]FMISO trapping challenging.
Our characterization of prominent [18F]FMISO trapping in perilesional regions is worth highlighting. Previous PET studies have shown severe derangements within and around cerebral contusions, but an increase in OEF consistent with cerebral ischemia is not always identified.5,36 We found that tissue within the vicinity of such lesions is hypoxic but does not fulfil the criteria for conventional macrovascular ischemia. An explanation for these findings comes from studies showing widespread microvascular occlusion and perivascular edema after TBI,16,49 associated with selective neuronal loss.17 Conventional physiology dictates that to maintain CMRO2 in the face of low CBF, OEF must be increased.1,33 However, hypoxic regions may be less able to increase OEF owing to an increased gradient for oxygen diffusion,15 which could explain our findings of low OEF and CBV despite evidence of low CBF and tissue hypoxia. Other studies have used diffusion-tensor imaging to demonstrate contusion expansion and that a rim of low apparent diffusion coefficient consistent with cytotoxic edema is often found surrounding contusions.30 This finding may characterize a region of microvascular failure and represent a traumatic penumbra that may be rescued by effective therapy such as hyperoxia14,39 or may be subsumed as the contusion enlarges.
These findings confirm the existence of diffusion hypoxia, characterize its pathophysiologic signature as distinct from conventional macrovascular ischemia, and show that diffusion hypoxia and macrovascular ischemia have incomplete spatial concordance. This physiologic signature is consistent with microvascular ischemia, and, importantly, this mechanism is also found within regions that appear structurally normal. Such findings require further scrutiny and are relevant to the development of future neuroprotective strategies.
Corresponding Author: Jonathan P. Coles, PhD, Division of Anaesthesia, University of Cambridge, Addenbrooke’s Hospital, Hills Road, PO Box 93, Cambridge CB2 0QQ, England (email@example.com).
Accepted for Publication: January 1, 2016.
Published Online: March 28, 2016. doi:10.1001/jamaneurol.2016.0091.
Author Contributions: Drs Menon and Coles are joint senior authors and contributed equally to the study. Dr Coles had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Veenith, Fryer, Menon, Coles.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Veenith, Newcombe, Gee, Aigbirhio, Fryer, Menon, Coles.
Critical revision of the manuscript for important intellectual content: Veenith, Carter, Geeraerts, Grossac, Newcombe, Outtrim, Lupson, Smith, Fryer, Hong, Menon, Coles.
Statistical analysis: Veenith, Geeraerts, Newcombe, Menon, Coles.
Obtained funding: Veenith, Newcombe, Fryer, Menon, Coles.
Administrative, technical, or material support: Veenith, Outtrim, Lupson, Smith, Aigbirhio, Fryer, Hong, Menon, Coles.
Study supervision: Fryer, Menon, Coles.
Conflict of Interest Disclosures: None reported.
Funding/Support: This study was supported by a clinical research training fellowship from National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship (Dr Veenith), a clinical research training fellowship from the Société Française d’Anesthésie et de Réanimation (Dr Geeraerts), a Clinician Scientist Fellowship from the Health Foundation/Academy of Medical Sciences (Dr Newcombe), a Senior Investigator Award from the National Institute for Health Research (Dr Menon), grant WT093267 from the Wellcome Trust Project, program grant G9439390 ID 65883 from the Medical Research Council (Acute Brain Injury: Heterogeneity of Mechanisms, Therapeutic Targets and Outcome Effects), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the UK Department of Health (Drs Aigbirhio, Fryer, Menon, and Coles, for the Technology Platform).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Josef Alawneh, PhD, Addenbrooke’s Hospital, Ramez Moustafa, PhD, Ain Shams University, Cairo, Egypt, and J. C. Baron, ScD, Institut National de la Santé et de la Recherche Medicale U894, Centre de Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Université Paris, helped with recruitment and acquisition of fluorine 18–labeled fluoromisonidazole positron emission tomography among the controls. No compensation was received for these contributions.